These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22086129)

  • 1. A conserved matrix epitope based DNA vaccine protects mice against influenza A virus challenge.
    Kumar P; Khanna M; Kumar B; Rajput R; Banerjea AC
    Antiviral Res; 2012 Jan; 93(1):78-85. PubMed ID: 22086129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In contrast to conventional inactivated influenza vaccines, 4xM2e.HSP70c fusion protein fully protected mice against lethal dose of H1, H3 and H9 influenza A isolates circulating in Iran.
    Ebrahimi SM; Dabaghian M; Tebianian M; Jazi MH
    Virology; 2012 Aug; 430(1):63-72. PubMed ID: 22595444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
    Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z
    J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.
    Fu TM; Guan L; Friedman A; Schofield TL; Ulmer JB; Liu MA; Donnelly JJ
    J Immunol; 1999 Apr; 162(7):4163-70. PubMed ID: 10201942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with high epitope density of M2e derived from 2009 pandemic H1N1 elicits protective immunity in mice.
    Zhou C; Zhou L; Chen YH
    Vaccine; 2012 May; 30(23):3463-9. PubMed ID: 22446634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
    Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
    Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of different DNA vaccines for protection of experimental influenza A virus infection.
    Wiesener N; Schütze T; Lapp S; Lehmann M; Jarasch-Althof N; Wutzler P; Henke A
    Viral Immunol; 2011 Aug; 24(4):321-30. PubMed ID: 21830903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.
    Huleatt JW; Nakaar V; Desai P; Huang Y; Hewitt D; Jacobs A; Tang J; McDonald W; Song L; Evans RK; Umlauf S; Tussey L; Powell TJ
    Vaccine; 2008 Jan; 26(2):201-14. PubMed ID: 18063235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo electroporation enhances immunogenicity and protection against influenza A virus challenge of an M2e-HSP70c DNA vaccine.
    Jazi MH; Dabaghian M; Tebianian M; Gharagozlou MJ; Ebrahimi SM
    Virus Res; 2012 Aug; 167(2):219-25. PubMed ID: 22609252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.
    Park KS; Seo YB; Lee JY; Im SJ; Seo SH; Song MS; Choi YK; Sung YC
    Vaccine; 2011 Jul; 29(33):5481-7. PubMed ID: 21664216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the vaccine potential of an influenza A viral hemagglutinin and matrix double insertion DNA plasmid.
    Xie H; Liu T; Chen H; Huang X; Ye Z
    Vaccine; 2007 Nov; 25(44):7649-55. PubMed ID: 17913307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
    Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
    J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The route of immunization with adenoviral vaccine influences the recruitment of cytotoxic T lymphocytes in the lung that provide potent protection from influenza A virus.
    Suda T; Kawano M; Nogi Y; Ohno N; Akatsuka T; Matsui M
    Antiviral Res; 2011 Sep; 91(3):252-8. PubMed ID: 21722671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin.
    Wang B; Yu H; Yang FR; Huang M; Ma JH; Tong GZ
    Virol J; 2012 Jun; 9():127. PubMed ID: 22738661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection.
    El Bakkouri K; Descamps F; De Filette M; Smet A; Festjens E; Birkett A; Van Rooijen N; Verbeek S; Fiers W; Saelens X
    J Immunol; 2011 Jan; 186(2):1022-31. PubMed ID: 21169548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model.
    Shen X; Söderholm J; Lin F; Kobinger G; Bello A; Gregg DA; Broderick KE; Sardesai NY
    Vaccine; 2012 Nov; 30(48):6946-54. PubMed ID: 22406460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterosubtypic immunity to influenza mediated by liposome adjuvanted H5N1 recombinant protein vaccines.
    Thueng-in K; Maneewatch S; Srimanote P; Songserm T; Tapchaisri P; Sookrung N; Tongtawe P; Channarong S; Chaicumpa W
    Vaccine; 2010 Sep; 28(41):6765-77. PubMed ID: 20688037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of effective constituents of influenza vaccine by immunization with plasmid DNAs encoding viral proteins.
    Ze C; Kurata T; Tamura S
    Jpn J Infect Dis; 2000 Dec; 53(6):219-28. PubMed ID: 11227019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA fusion vaccines incorporating IL-23 or RANTES for use in immunization against influenza.
    Williman J; Young S; Buchan G; Slobbe L; Wilson M; Pang P; Austyn J; Preston S; Baird M
    Vaccine; 2008 Sep; 26(40):5153-8. PubMed ID: 18456374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection.
    Patel A; Gray M; Li Y; Kobasa D; Yao X; Kobinger GP
    Vaccine; 2012 Jan; 30(3):626-36. PubMed ID: 22119588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.